Abstract
New anti-Helicobacter pylori (H. pylori) agents endowed with H2-antagonists properties were obtained by combining the lamtidine derived pharmacophoric group with the antibiotic calvatic acid. All the compounds were tested for their irreversible H2-antagonist properties and for their ability to inhibit 20 H. pylori strains, two of them metronidazole resistant. The most active derivative (compound 4) displayed antimicrobial activity similar to metronidazole.
| Lingua originale | Inglese |
|---|---|
| pagine (da-a) | 403-406 |
| Numero di pagine | 4 |
| Rivista | Bioorganic and Medicinal Chemistry Letters |
| Volume | 11 |
| Numero di pubblicazione | 3 |
| DOI | |
| Stato di pubblicazione | Pubblicato - 12 feb 2001 |
| Pubblicato esternamente | Sì |